[ad_1]
Under the measure "Intelligence Joint Scientific Projects" will be implemented by the project "Development and Certification of Intelligent Heart Failure Monitoring System". UAB Zivė – a technology company that develops innovative medical devices, will invest 230,000 euros in the implementation of the project from the European Union's (EU) structural funds. Eur.
UAB Zivės will strive to meet market needs for non-intrusive, intrusive and irregular heart rate monitoring for both cardiovascular risk groups and those who care for their cardiovascular prevention. .
The company's implementation project will create and certify a personalized, non-invasive and commercial heart rate monitoring system consisting of three smart devices and software. The system will ensure the identification of the primary paroxysmal atrial fibrillation epithelium in the short term in an ambulatory cardiac monitoring system; the identification of random signals, the identification of medically relevant results in the sequence of random signals, and the determination of trends in heart rate variability.
Long-term monitoring of heart rhythm and short-term conduction disorders will not limit the agility and lifestyle of individuals, but the technical characteristics of heart rate recorders will provide long-term monitoring term accurate heartbeat.
According to the World Health Organization, cardiovascular diseases cause 17.5 million deaths a year, accounting for 31% of all deaths. Disease prevention measures, as well as personal monitoring of cardiac activity at home, are becoming increasingly important for ensuring adequate health care. Cardiac monitoring devices already have a Holter sensor, for example, but they are expensive and impractical for home use and are for professional medical diagnosis, but not for the prevention of cardiovascular disease.
The total cost of the project is 361 thousand. Eur, the project is implemented with the partner of UAB Astra Minerva.
Source link
